| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Mar―18 |
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19 |
Sam Schulman, Donald M. Arnold, Charlotte A. Bradbury, Lisa Broxmeyer, Jean Marie Connors, Anna Falanga, Toshiaki Iba, Scott Kaatz, Jerrold H. Levy, Saskia Middeldorp, Tracy Minichiello, Ishac Nazy, Eduardo Ramacciotti, Helaine E. Resnick, Charles Marc Samama, Michelle Sholzberg, Jecko Thachil, Ryan Zarychanski, Alex C. Spyropoulos |
| 2 |
[GO] |
2024―Mar―05 |
Role of Microbiota-Derived Corisin in Coagulation Activation during SARS-CoV-2 Infection |
Tatsuki Tsuruga, Hajime Fujimoto, Taro Yasuma, Corina N. D’Alessandro-Gabazza, Masaaki Toda, Toshiyuki Ito, Atsushi Tomaru, Haruko Saiki, Tomohito Okano, Manal A.B. Alhawsawi, Atsuro Takeshita, Kota Nishihama, Reoto Takei, Yasuhiro Kondoh, Isaac Cann, Esteban C. Gabazza, Tetsu Kobayashi. |
| 3 |
[GO] |
2024―Feb―29 |
Four years into the pandemic, managing COVID-19 patients with acute coagulopathy: what have we learned? |
Toshiaki Iba, Jerrold H. Levy, Cheryl L. Maier, Jean M. Connors, Marcel Levi |
| 4 |
[GO] |
2024―Feb―02 |
Uncertainties about the roles of anticoagulation and microclots in post-acute sequelae of SARS-CoV-2 infection-response to the letter by Kell et al. |
Jean M. Connors, Robert A.S. Ariëns |
| 5 |
[GO] |
2024―Feb―02 |
Uncertainties about the roles of anticoagulation and microclots in postacute sequelae of SARS-CoV-2 infection: comment from Kell et al. |
Douglas B. Kell, M. Asad Khan, Gert Jacobus Laubscher, Etheresia Pretorius |
| 6 |
[GO] |
2023―Oct―04 |
COVID-19 promotes endothelial dysfunction and thrombogenicity: Role of pro-inflammatory cytokines/SGLT2 pro-oxidant pathway |
Ali Mroueh, Walaa Fakih, Adrien Carmona, Antonin Trimaille, Kensuke Matsushita, Benjamin Marchandot, Abdul Wahid Qureshi, Dal-Seong Gong, Cyril Auger, Laurent Sattler, Antje Reydel, Sébastien Hess, Walid Oulehri, Olivier Vollmer, Jean-Marc Lessinger, Nicolas Meyer, Michael-Paul Pieper, Laurence Jesel, Magnus Bäck, Valérie Schini-Kerth, Olivier Morel |
| 7 |
[GO] |
2023―Sep―23 |
NETs induce persistent lung tissue damage via thromboinflammation without altering virus resolution in a mouse coronavirus model |
Manuel Salzmann, Patrizia Gibler, Patrick Haider, Mira Brekalo, Roberto Plasenzotti, Thomas Filip, Rebecca Nistelberger, Boris Hartmann, Johann Wojta, Christian Hengstenberg, Bruno K. Podesser, Julia B. Kral-Pointner, Philipp J. Hohensinner |
| 8 |
[GO] |
2023―Aug―07 |
Characterization of all small RNAs in and comparisons across cultured megakaryocytes and platelets of healthy individuals and COVID-19 patients |
Stepan Nersisyan, Emilie Montenont, Phillipe Loher, Elizabeth A. Middleton, Robert Campbell, Paul Bray, Isidore Rigoutsos |
| 9 |
[GO] |
2023―Jul―25 |
Uncertainties about the Roles of Anticoagulation and Microclots in Post-acute Sequelae of SARS-CoV-2 Infection |
Jean M. Connors, Robert A.S. Ariëns |
| 10 |
[GO] |
2023―Jul―17 |
A commentary on “Thromboinflammation in long COVID - the elusive key to post-infection sequelae?” |
Toshiaki Iba, Jerrold H. Levy |
| 11 |
[GO] |
2023―Jul―08 |
Thrombosis, major bleeding, and survival in COVID-19 supported by VV- ECMO in the first vs second wave- multicentre observational study in the UK. |
Deepa J. Arachchillage, Anna Weatherill, Indika Rajakaruna, Mihaela Gaspar, Zain Odho, Graziella Isgro, Lenka Cagova, Lucy Fleming, Stephane Ledot, Mike Laffan, Richard Szydlo, Rachel Jooste, Ian Scott, Alain Vuylsteke, Hakeem Yusuff |
| 12 |
[GO] |
2023―Jun―01 |
Thrombotic Complications in Children with COVID-19 and MIS-C |
Riten Kumar, Michael J. Rivkin, Leslie Raffini |
| 13 |
[GO] |
2023―May―23 |
A RANDOMISED CONTROLLED TRIAL TO INVESTIGATE THE USE OF ACUTE CORONARY SYNDROME THERAPY IN PATIENTS HOSPITALISED WITH COVID-19: THE C19-ACS TRIAL |
Prapa Kanagaratnam, Darrel P. Francis, Daniel Chamie, Clare Coyle, Alena Marynina, George Katritsis, Patricia Paiva, Matyas Szigeti, Graham Cole, David de Andrade Nunes, James Howard, Rodrigo Esper, Masood Khan, Ranjit More, Guilherme Barreto, Rafael Meneguz-Moreno, Ahran Arnold, Alexandra Nowbar, Amit Kaura, Myril Mariveles, Katherine March, Jaymin Shah, Sukhjinder Nijjer, Gregory YH. Lip, Nicholas Mills, A John Camm, Graham S. Cooke, Simon J. Corbett, Martin J. Llewelyn, Waleed Ghanima, Mark Toshner, Nicholas Peters, Ricardo Petraco, Rasha Al-Lamee, Ana Sousa Marcelino Boshoff, Margarita Durkina, Iqbal Malik, Neil Ruparelia, Victoria Cornelius, Matthew Shun-Shin |
| 14 |
[GO] |
2023―May―13 |
COVID-19 outcomes in persons with hemophilia: results from a US-based national COVID-19 surveillance registry |
Anjali Sharathkumar, Linder Wendt, Chris Ortman, Ragha Srinivasan, Christopher Chute, Elizabeth Chrischilles, Clifford Takemoto |
| 15 |
[GO] |
2023―May―11 |
Thrombo-inflammation in Long COVID - the elusive key to post-infection sequelae? |
Leo Nicolai, Rainer Kaiser, Konstantin Stark |
| 16 |
[GO] |
2023―Apr―11 |
NETosis induction reflects COVID-19 severity and Long COVID: insights from a two-center patient cohort study in Israel |
Nitzan Krinsky, Sofia Sizikov, Sivan Nissim, Adi Dror, Anna Sas, Hodaya Prinz, Ester Pri-Or, Shay Perek, Ayelet Raz-Pasteur, Izabella Lejbkowicz, Sivan Ida Cohen-Matsliah, Ronit Almog, Nikanor Chen, Ramzi Kurd, Amir Jarjou'i, Ariel Rokach, Eli Ben-Chetrit, Avi Schroeder, Aleah F. Caulin, Christian Con Yost, Joshua D. Schiffman, Mor Goldfeder, Kimberly Martinod |
| 17 |
[GO] |
2023―Mar―12 |
Distinct platelet crosstalk with adaptive and innate immune cells after adenoviral and mRNA vaccination against SARS-CoV-2. |
Ludovica Lombardi, Francesca Maiorca, Ramona Marrapodi, Annamaria Sabetta, Noemi Scafa, Davide Pallucci, Marzia Miglionico, Giulio F. Romiti, Bernadette Corica, Silvia Piconese, Antonella Polimeni, Fabio Pulcinelli, Roberto Cangemi, Marcella Visentini, Stefania Basili, Lucia Stefanini |
| 18 |
[GO] |
2023―Feb―28 |
“Thromboinflammation in COVID-19: can α2-macroglobulin help to control the fire?”: Comment from Seitz et al. |
Rainer Seitz, Lutz Gürtler, Wolfgang Schramm |
| 19 |
[GO] |
2023―Jan―28 |
Alterations in platelet proteome signature and impaired platelet integrin αIIbβ3 activation in patients with COVID-19 |
Lucy J. Goudswaard, Christopher M. Williams, Jawad Khalil, Kate L. Burley, Fergus Hamilton, David Arnold, Alice Milne, Phil A. Lewis, Kate J. Heesom, Stuart J. Mundell, Andrew D. Davidson, Alastair W. Poole, Ingeborg Hers |
| 20 |
[GO] |
2023―Jan―25 |
Peripheral blood mononuclear cell tissue factor (F3 gene) transcript levels and circulating extracellular vesicles are elevated in severe COVID-19 disease |
Thomas J. Girard, Lilian Antunes Heck, Nan Zhang, Junedh M. Amrute, Renumathi Subramanian, Irem Eldem, Kenneth E. Remy, Monty Mazer, Emma C. Erlich, Carlos Cruchaga, Ashley L. Steed, Gwendalyn J. Randolph, Jorge Di Paola |
| 21 |
[GO] |
2022―Oct―22 |
“
ISTH
guidelines for antithrombotic treatment in COVID-19”: Reply |
Sam Schulman, Michelle Sholzberg, Alex C. Spyropoulos, Ryan Zarychanski |
| 22 |
[GO] |
2022―Aug―25 |
Most impactful COVID-19 articles in the field of thrombosis and hemostasis literature |
Eyal Klang, Gili Kenet, Sarina Levy-Mendelovich |
| 23 |
[GO] |
2022―Aug―15 |
“Unconventional
CD147
-dependent platelet activation elicited by
SARS-CoV
-2 in
COVID
-19”: Comment from Wada et al |
Hideo Wada, Katsuya Shiraki, Katsue Suzuki-Inoue |
| 24 |
[GO] |
2022―Aug―15 |
“Unconventional
CD147
-dependent platelet activation elicited by
SARS-CoV
-2 in
COVID
-19”: Reply |
Norma Maugeri, Angelo A. Manfredi |
| 25 |
[GO] |
2022―Jul―25 |
Sustained
VWF-ADAMTS13
axis imbalance and endotheliopathy in Long
COVID
syndrome is related to immune dysfunction |
Helen Fogarty, Soracha E. Ward, Liam Townsend, Ellie Karampini, Stephanie Elliott, Niall Conlon, Jean Dunne, Rachel Kiersey, Aifric Naughton, Mary Gardiner, Mary Byrne, Colm Bergin, Jamie M. O’Sullivan, Ignacio Martin-Loeches, Parthiban Nadarajan, Ciaran Bannan, Patrick W. Mallon, Gerard F. Curley, Roger J. S. Preston, Aisling M. Rehill, Ross I. Baker, Cliona Ni Cheallaigh, James S. O’Donnell |
| 26 |
[GO] |
2022―Jun―27 |
Commentary on “Risk of venous thromboembolism after COVID-19 vaccination” |
Corinne Frere, Joe-Elie Salem |
| 27 |
[GO] |
2022―May―21 |
The thrombosis and haemostasis community network come face-to-face in a new (almost) post pandemic world |
Beverley Hunt, Robert A. S. Ariëns |
| 28 |
[GO] |
2022―May―05 |
Refractory immune TTP following Pfizer-BioNTech COVID-19 vaccine successfully salvaged with caplacizumab |
Eva Laverdure, Catherine Sperlich, Susan Fox |
| 29 |
[GO] |
2022―Apr―10 |
Risk of Venous Thromboembolism after COVID-19 Vaccination |
Damon E. Houghton, Waldemar Wysokinski, Ana I. Casanegra, Leslie J. Padrnos, Surbhi Shah, Ewa Wysokinska, Rajiv Pruthi, Aneel Ashrani, Meera Sridharan, Lisa Baumann-Kreuziger, Robert McBane, Anand Padmanabhan |
| 30 |
[GO] |
2022―Mar―22 |
Altered fibrin network structure and fibrinolysis in intensive care unit patients with COVID-19, not entirely explaining the increased risk of thrombosis |
Judith J. de Vries, Chantal Visser, Lotte Geers, Johan A. Slotman, Nadine D. van Kleef, Coen Maas, Hannelore I. Bax, Jelle R. Miedema, Eric C.M. van Gorp, Marco Goeijenbier, Johannes P.C. van den Akker, Henrik Endeman, Dingeman C. Rijken, Marieke J.H.A. Kruip, Moniek P.M. de Maat |
| 31 |
[GO] |
2022―Mar―22 |
Bleeding risk of intramuscular injection of COVID-19 vaccines in adult patients with therapeutic anticoagulation |
Nicolas Gendron, Lina Khider, Christine Le Beller, Benjamin Espinasse, Claire Auditeau, Wafa Amara, Germain Perrin, David Lebeaux, Anais Gaiffe, Sandrine Combret, Blandine Bertin, Agnès Lillo-Le Louet, Tristan Mirault, David M Smadja, Olivier Sanchez, Cécile Tromeur, Benjamin Planquette, Francis Couturaud |
| 32 |
[GO] |
2022―Mar―21 |
Real world, single centre experience of SARS-CoV-2 vaccination in Immune Thrombocytopenia |
Philippa Woolley, Anish Tailor, Raakhee Shah, John-Paul Westwood, Marie Scully |
| 33 |
[GO] |
2022―Feb―27 |
Scientific method and the COVID pandemic |
David Lillicrap, James H. Morrissey |
| 34 |
[GO] |
2022―Feb―17 |
Shining a Light on Platelet Activation in COVID-19 |
Frederik Denorme, Abigail Ajanel, Robert A. Campbell |
| 35 |
[GO] |
2022―Feb―14 |
Platelet size as a mirror for the immune response after SARS-CoV-2 vaccination |
Thomas Thiele, Silas L. Schwarz, Stefan Handtke |
| 36 |
[GO] |
2022―Feb―12 |
Thrombosis pathways in COVID-19 versus influenza-associated ARDS: a targeted proteomics approach |
Emma Rademaker, Dennis J. Doorduijn, Nuray Kusadasi, Coen Maas, Julia Drylewicz, Albert Huisman, Imo E. Hoefer, Marc J. M. Bonten, Lennie P. G. Derde, Suzan H. M. Rooijakkers, Olaf L. Cremer |
| 37 |
[GO] |
2022―Feb―02 |
Investigating potential mechanisms underlying FVIII inhibition in acquired hemophilia A associated with mRNA COVID-19 vaccines |
Julia R. Hirsiger, Maria Martinez, Dimitrios A. Tsakiris, Micol G. Cittone, Lukas Graf, Johannes Oldenburg, Behnaz Pezeshkpoor, Mike Recher, Jens Mueller, Bernhard Gerber, Christoph T. Berger |
| 38 |
[GO] |
2022―Feb―01 |
Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis |
Sarah Kelliher, Luisa Weiss, Sarah Cullivan, Ellen O’Rourke, Claire A. Murphy, Shane Toolan, Áine Lennon, Paulina B. Szklanna, Shane P. Comer, Hayley Macleod, Ana Le Chevillier, Sean Gaine, Kate M. A. O’Reilly, Brian McCullagh, John Stack, Patricia B. Maguire, Fionnuala Ní Áinle, Barry Kevane |
| 39 |
[GO] |
2022―Jan―15 |
Impact of COVID-19 on thrombus composition and response to thrombolysis: Insights from a monocentric cohort population of COVID-19 patients with acute ischemic stroke |
Jean-Philippe Desilles, Mialitiana Solo Nomenjanahary, Arturo Consoli, Véronique Ollivier, Dorothée Faille, Marie-Charlotte Bourrienne, Mylène Hamdani, Sébastien Dupont, Lucas Di Meglio, Simon Escalard, Benjamin Maier, Raphael Blanc, Michel Piotin, Bertrand Lapergue, Nadine Ajzenberg, Marc Vasse, Mikael Mazighi, Benoît Ho-Tin-Noé |
| 40 |
[GO] |
2022―Jan―15 |
Platelet and immune signature associated with a rapid response to the BNT162b2 mRNA Covid-19 Vaccine |
Davide Flego, Simone Cesaroni, Giulio F. Romiti, Bernadette Corica, Ramona Marrapodi, Noemi Scafa, Francesca Maiorca, Ludovica Lombardi, Davide Pallucci, Fabio Pulcinelli, Valeria Raparelli, Marcella Visentini, Roberto Cangemi, Silvia Piconese, Domenico Alvaro, Antonella Polimeni, Stefania Basili, Lucia Stefanini |
| 41 |
[GO] |
2021―Dec―31 |
The COVID-19 vaccine ChAdOx1-S is not contaminated with sulfated glycosaminoglycans |
Susanne Alban, Sandesh Neupane, Ulrich Girreser, Frank D. Sönnichsen, Andreas Greinacher |
| 42 |
[GO] |
2021―Nov―19 |
COVID-19 - Two years in |
David Lillicrap, James H. Morrissey |
| 43 |
[GO] |
2021―Nov―09 |
Antibody-mediated procoagulant platelet formation in COVID-19 is AKT dependent |
Lisann Pelzl, Anurag Singh, Jonas Funk, Andreas Witzemann, Irene Marini, Jan Zlamal, Karoline Weich, Wissam Abou-Khalel, Stefanie Hammer, Guenalp Uzun, Karina Althaus, Tamam Bakchoul |
| 44 |
[GO] |
2021―Nov―05 |
More on Persistent Endotheliopathy in the Pathogenesis of Long COVID Syndrome |
Helen Fogarty, Ellie Karampini, Andrew S. O’Donnell, Soracha E. Ward, Jamie M O’Sullivan, James S. O’Donnell |
| 45 |
[GO] |
2021―Nov―03 |
Persistent Endotheliopathy in the Pathogenesis of Long COVID Syndrome: COMMENT from von Meijenfeldt et al. |
Fien A. von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, Charlotte Thalin, Ton Lisman |
| 46 |
[GO] |
2021―Oct―28 |
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19 |
Norma Maugeri, Rebecca De Lorenzo, Nicola Clementi, Roberta Antonia Diotti, Elena Criscuolo, Cosmo Godino, Cristina Tresoldi, Chiara Bonini, Massimo Clementi, Nicasio Mancini, Fabio Ciceri, Patrizia Rovere-Querini, Angelo A Manfredi |
| 47 |
[GO] |
2021―Oct―21 |
Role of neutrophils, platelets and extracellular vesicles and their interactions in Covid-19-associated thrombopathy |
Antoine Caillon, Antonin Trimaille, Julie Favre, Laurence Jesel, Olivier Morel, Gilles Kauffenstein |
| 48 |
[GO] |
2021―Sep―19 |
Use of Novel Antithrombotic Agents for COVID-19: Systemic Summary of Ongoing Randomized Controlled Trials |
Azita H. Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, Hessam Kakavand, Hamid Ariannejad, Jean M. Connors, Beverley J. Hunt, Jeffrey S. Berger, Benjamin W. Van Tassell, Saskia Middeldorp, Gregory Piazza, Jeffrey I. Weitz, Mary Cushman, Gregory Y.H. Lip, Samuel Z. Goldhaber, Behnood Bikdeli |
| 49 |
[GO] |
2021―Sep―19 |
Pathology of lung-specific thrombosis and inflammation in COVID-19 |
Rafael R. Khismatullin, Anastasia A. Ponomareva, Chandrasekaran Nagaswami, Rozalina A. Ivaeva, Kathleen T. Montone, John W. Weisel, Rustem I. Litvinov |
| 50 |
[GO] |
2021―Sep―19 |
Platelets Contribute to Disease Severity in COVID-19 |
Tessa J. Barrett, Seda Bilaloglu, Macintosh Cornwell, Hannah M Burgess, Vitor W Virginio, Kamelia Drenkova, Homam Ibrahim, Eugene Yuriditsky, Yin Aphinyanaphongs, Mark Lifshitz, Feng Xia Liang, Julie Alejo, Grace Smith, Stefania Pittaluga, Amy V Rapkiewicz, Jun Wang, Camelia Iancu-Rubin, Ian Mohr, Kelly Ruggles, Kenneth A. Stapleford, Judith Hochman, Jeffrey S. Berger |
| 51 |
[GO] |
2021―Aug―29 |
Association of Pre-Hospital Antiplatelet Therapy with Survival in Patients Hospitalized with COVID-19: A Propensity Score-Matched Analysis |
Jonathan H. Chow, Ying Yin, David P. Yamane, Danielle Davison, Ryan Keneally, Katrina Hawkins, Gage Parr, Mustafa Al-Mashat, Jeffery S. Berger, Reamer L. Bushardt, Michael A. Mazzeffi, Stuart J. Nelson |
| 52 |
[GO] |
2021―Aug―26 |
Impact of the COVID-19 pandemic on education and clinical training |
Muntadhar Al Moosawi, Aaron Iding, Paul Armstrong, Thita Chiasakul, Robert Campbell, Caterina Casari, Claire McLintock, Muntadhar Al Moosawi, Paul Armstrong, Rose Brazilek, Robert Campbell, Caterina Casari, Thita Chiasakul, Sofija Dunjic Manevski, Renee Eslick, Aaron Iding, Shrey Kohli, Lauren Poole, Leslie Skeith |
| 53 |
[GO] |
2021―Aug―21 |
Tissue factor expression, extracellular vesicles and thrombosis after infection with the respiratory viruses influenza A virus and coronavirus |
Nigel Mackman, Steven P Grover, Silvio Antoniak |
| 54 |
[GO] |
2021―Aug―12 |
Education of healthcare professionals and the public about thrombosis and COVID-19 |
Beverley Hunt |
| 55 |
[GO] |
2021―Aug―10 |
Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: thrombosis at unusual sites |
Maria Abbattista, Ida Martinelli, Flora Peyvandi |
| 56 |
[GO] |
2021―Aug―10 |
Persistent Endotheliopathy in the Pathogenesis of Long COVID Syndrome |
Helen Fogarty, Liam Townsend, Hannah Morrin, Azaz Ahmad, Claire Comerford, Ellie Karampini, Hanna Englert, Mary Byrne, Colm Bergin, Jamie M. O’Sullivan, Ignacio Martin-Loeches, Parthiban Nadarajan, Ciaran Bannan, Patrick W. Mallon, Gerard F. Curley, Roger J.S. Preston, Aisling M. Rehill, Dennis McGonagle, Cliona Ni Cheallaigh, Ross I. Baker, Thomas Renné, Soracha E. Ward, James S. O’ Donnell |
| 57 |
[GO] |
2021―Jul―31 |
Reply to the letter entitled “Suggested treatment of serious complications to Covid-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme” |
Yves Gruel, Caroline Vayne, Jérôme Rollin, Claire Pouplard |
| 58 |
[GO] |
2021―Jul―27 |
Laboratory testing for post ChAdOx1 nCOV-19 vaccination VITT: A challenge.
Comment on: Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: Communication from the ISTH SSC Subcommittee on Platelet Immunology |
Kobe Vercruysse, Katrien M. J. Devreese |
| 59 |
[GO] |
2021―Jul―17 |
Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine: COMMENT: COMMENT from Gruel et al.: RESPONSE from Kahn et al. |
Fredrik Kahn, Oongh Shannon, Lars Björck |
| 60 |
[GO] |
2021―Jul―14 |
The CoVID-TE Risk Assessment Model for Venous Thromboembolism in Hospitalized Patients with Cancer and COVID-19 |
Ang Li, Nicole M. Kuderer, Chih-Yuan Hsu, Yu Shyr, Jeremy L. Warner, Dimpy P. Shah, Vaibhav Kumar, Surbhi Shah, Amit A. Kulkarni, Julie Fu, Shuchi Gulati, Rebecca L. Zon, Monica Li, Aakash Desai, Pamela C. Egan, Ziad Bakouny, Devendra KC, Clara Hwang, Imo J. Akpan, Rana R. McKay, Jennifer Girard, Andrew L. Schmidt, Balazs Halmos, Michael A. Thompson, Jaymin M. Patel, Nathan A. Pennell, Solange Peters, Amro Elshoury, Gilbero de Lima Lopes, Daniel G. Stover, Petros Grivas, Brian I. Rini, Corrie A. Painter, Sanjay Mishra, Jean M. Connors, Gary H. Lyman, Rachel P. Rosovsky |
| 61 |
[GO] |
2021―Jul―14 |
Physician Experiences in Management of COVID-19-Associated Coagulopathy in Pregnancy: Communication from the ISTH SSC Subcommittee on Women's Health Issues in Thrombosis and Haemostasis |
Stefan D. Jevtic, A. Kinga Malinowski, Maha Othman, Rezan A Abdul Kadir |
| 62 |
[GO] |
2021―Jul―09 |
Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19 |
Anne Hollerbach, Nadine Müller-Calleja, Denise Pedrosa, Antje Canisius, Martin F. Sprinzl, Tanja Falter, Heidi Rossmann, Marc Bodenstein, Christian Werner, Ingo Sagoschen, Thomas Münzel, Oliver Schreiner, Visvakanth Sivanathan, Michael Reuter, Johannes Niermann, Peter R. Galle, Luc Teyton, Wolfram Ruf, Karl J. Lackner |
| 63 |
[GO] |
2021―Jul―09 |
Remote history of VTE is associated with severe COVID-19 in middle and older age: UK Biobank cohort study |
Jana J Anderson, Frederick K Ho, Claire L Niedzwiedz, S. Vittal Katikireddi, Carlos Celis-Morales, Stamatina Iliodromiti, Paul Welsh, Pierpaolo Pellicori, Evangelia Demou, Claire E Hastie, Donald M Lyall, Stuart R Gray, John F Forbes, Jason MR Gill, Daniel F Mackay, Colin Berry, John GF Cleland, Naveed Sattar, Jill P Pell |
| 64 |
[GO] |
2021―Jul―08 |
Tissue Factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients |
Sandeep Subrahmanian, Alain Borczuk, Steven Salvatore, Kar-Ming Fung, Joan T. Merrill, Jeffrey Laurence, Jasimuddin Ahamed |
| 65 |
[GO] |
2021―Jul―08 |
Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: a multi-center, open-label, randomized controlled trial |
Usha S. Perepu, Isaac Chambers, Abdul Wahab, Patrick Ten Eyck, Chaorong Wu, Sanjana Dayal, Grerk Sutamtewagul, Steven R. Bailey, Lori J. Rosenstein, Steven R. Lentz |
| 66 |
[GO] |
2021―Jul―05 |
Imbalanced of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically-ill COVID-19 patients |
Bérangère S. Joly, Michael Darmon, Charlotte Dekimpe, Thibault Dupont, Guillaume Dumas, Elise Yvin, Nicolas Beranger, Karen Vanhoorelbeke, Elie Azoulay, Agnès Veyradier |
| 67 |
[GO] |
2021―Jun―24 |
Suggested treatment of serious complications to Covid-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme |
Fredrik Kahn, Oonagh Shannon, Lars Björck |
| 68 |
[GO] |
2021―Jun―02 |
ADAMTS13 regulation of VWF multimer distribution in severe COVID-19 |
Soracha E. Ward, Helen Fogarty, Ellie Karampini, Michelle Lavin, Sonja Schneppenheim, Rita Dittmer, Hannah Morrin, Siobhan Glavey, Cliona Ni Cheallaigh, Colm Bergin, Ignacio Martin-Loeches, Patrick W. Mallon, Gerard F. Curley, Ross I. Baker, Ulrich Budde, Jamie M. O’Sullivan, James S. O’ Donnell, Niamh O’Connell, Kevin Ryan, Mary Byrne, Liam Townsend, Natalie L McEvoy, Jennifer Clarke, Maria Boylan, Razi Alalqam, Amy P Worrall, Claire Kelly, Eoghan de Barra, Roger Preston Dermot Kenny |
| 69 |
[GO] |
2021―May―21 |
Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis |
Pablo Demelo-Rodriguez, Ana Isabel Farfán-Sedano, José María Pedrajas, Pilar Llamas, Patricia Sigüenza, María Jesús Jaras, Manuel Quintana-Diaz, Carmen Fernández-Capitán, Behnood Bikdeli, David Jiménez, Manuel Monreal |
| 70 |
[GO] |
2021―May―11 |
Evaluation of laboratory assays for anti-Platelet Factor 4 antibodies after ChAdOx1 nCOV-19 vaccination |
Sean Platton, Andrew Bartlett, Peter MacCallum, Mike Makris, Vickie McDonald, Deepak Singh, Marie Scully, Sue Pavord |
| 71 |
[GO] |
2021―Apr―28 |
An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination |
Ingvild Hausberg Sørvoll, Kjersti Daae Horvei, Siw Leiknes Ernstsen, Ingvild Jenssen Lægreid, Svetlana Lund, Renathe Henriksen Grønli, Magnus Kringstad Olsen, Hege Karine Jacobsen, Anna Eriksson, Anne Marie Halstensen, Eirik Tjønnfjord, Waleed Ghanima, Maria Therese Ahlen |
| 72 |
[GO] |
2021―Apr―27 |
Post adenoviral-based COVID-19 vaccines thrombosis: A proposed mechanism |
Kamran Kadkhoda |
| 73 |
[GO] |
2021―Apr―22 |
Recommendations for the clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia (VITT) for SARS-CoV-2 infections: Communication from the ISTH SSC Subcommittee on Platelet Immunology. |
Ishac Nazy, Ulrich J Sachs, Donald M. Arnold, Steven E McKenzie, Phil Choi, Karina Althaus, Maria Therese Ahlen, Ruchika Sharma, Rachael F Grace, Tamam Bakchoul |
| 74 |
[GO] |
2021―Apr―21 |
Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine |
Rolf Ankerlund Blauenfeldt, Søren Risom Kristensen, Siw Leiknes Ernstsen, Claudia Christina Hilt Kristensen, Claus Ziegler Simonsen, Anne-Mette Hvas |
| 75 |
[GO] |
2021―Apr―21 |
Antibody-mediated platelet activation in COVID-19: A coincidence or a new mechanism of the dysregulated coagulation system? |
Karina Althaus, Jan Zlamal, Tamam Bakchoul |
| 76 |
[GO] |
2021―Apr―08 |
Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality |
David M. Smadja, Aurélien Philippe, Olivier Bory, Nicolas Gendron, Agathe Beauvais, Maxime Gruest, Nicolas Peron, Lina Khider, Coralie L. Guerin, Guillaume Goudot, Françoise Levavasseur, Jérome Duchemin, Frédéric Pene, Cherifa Cheurfa, Tali-Anne Szwebel, Elise Sourdeau, Benjamin Planquette, Caroline Hauw-Berlemont, Bertrand Hermann, Pascale Gaussem, Charles-Marc Samama, Tristan Mirault, Benjamin Terrier, Olivier Sanchez, Bastien Rance, Michaela Fontenay, Jean-Luc Diehl, Richard Chocron |
| 77 |
[GO] |
2021―Apr―07 |
Biomarkers of coagulation, endothelial function and fibrinolysis in critically-ill patients with COVID-19: A single-centre prospective longitudinal study |
Ganeem K. Juneja, Matthew Castelo, Calvin H. Yeh, Samantha E. Cerroni, Bettina E. Hansen, James E. Chessum, Joel Abraham, Erblin Cani, Dhruva J. Dwivedi, Douglas D. Fraser, Marat Slessarev, Claudio Martin, Scott McGilvray, Peter L. Gross, Patricia C. Liaw, Jeffrey I. Weitz, Paul Y. Kim |
| 78 |
[GO] |
2021―Mar―30 |
A Case Report of Acquired Haemophilia following COVID-19 Vaccine |
Mansoor Radwi, Sara Farsi |
| 79 |
[GO] |
2021―Mar―28 |
Bleeding Risk by Intensity of Anticoagulation in Critically Ill Patients with COVID-19: A Retrospective Cohort Study |
Rim Halaby, Adam Cuker, Jennifer Yui, Andrew Matthews, Ella Ishaaya, Elizabeth Traxler, Christopher Domenico, Tara Cooper, Ann Tierney, Pardis Niami, Nathalie van der Rijst, Srinath Adusumalli, Jacob Gutsche, Jay Giri, Steven Pugliese, Todd E.H. Hecht, Allyson M. Pishko |
| 80 |
[GO] |
2021―Mar―16 |
Similarities and Perspectives on the two C’s - Cancer and COVID-19 |
Jecko Thachil, Alok Khorana, Marc Carrier |
| 81 |
[GO] |
2021―Feb―27 |
Platelet-Activating Immune Complexes Identified in Critically Ill COVID-19 Patients Suspected of Heparin-Induced Thrombocytopenia |
Ishac Nazy, Stefan D Jevtic, Jane C Moore, Angela Huynh, James W Smith, John G Kelton, Donald M Arnold |
| 82 |
[GO] |
2021―Feb―18 |
Prolonged elevation of D-dimer Levels in Convalescent COVID-19 patients is Independent of the Acute Phase Response |
Liam Townsend, Helen Fogarty, Adam Dyer, Ignacio Martin-Loeches, Ciaran Bannan, Parthiban Nadarajan, Colm Bergin, Cliona O’ Farrelly, Niall Conlon, Nollaig M. Bourke, Soracha E. Ward, Mary Byrne, Kevin Ryan, Niamh O’ Connell, Jamie M. O’ Sullivan, Cliona Ni Cheallaigh, James S. O’ Donnell |
| 83 |
[GO] |
2021―Feb―07 |
COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies |
Justine Brodard, Johanna A. Kremer Hovinga, Pierre Fontana, Jan-Dirk Studt, Yves Gruel, Andreas Greinacher |
| 84 |
[GO] |
2021―Feb―06 |
Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study |
Jun-Ying Li, Hong-Fei Wang, Ping Yin, Di Li, Di-Le Wang, Peng Peng, Wei-Hua Wang, Lan Wang, Xiao-Wei Yuan, Jin-Yuan Xie, Fan Zhou, Nian Xiong, Feng Shao, Chun-Xiu Wang, Xiang Tong, Hao Ye, Wen-Jun Wan, Ben-De Liu, Wen-Zhu Li, Qian Li, Liang V. Tang, Yu Hu, Gregory YH Lip |
| 85 |
[GO] |
2020―Dec―31 |
Thrombotic thrombocytopenic Purpura as the initial Presentation of COVID-19 |
Marie-Claude Beaulieu, Danny Sebastien Mettelus, Benjamin Rioux-Massé, Michèle Mahone |
| 86 |
[GO] |
2020―Dec―31 |
Thrombotic thrombocytopenic purpura (TTP) response following COVID-19 infection: implications for the ADAMTS13-von Willebrand factor axis |
Satish Maharaj, Ruobing Xue, Adam Rojan |
| 87 |
[GO] |
2020―Dec―11 |
SARS-CoV-2 Associated Coagulopathy And Thromboembolism Prophylaxis In Children: A Single Centre Observational Study |
Giovanni Del Borrello, Isaac Giraudo, Claudia Bondone, Marco Denina, Silvia Garazzino, Claudia Linari, Federica Mignone, Giulia Pruccoli, Carlo Scolfaro, Manuela Spadea, Berardino Pollio, Paola Saracco |
| 88 |
[GO] |
2020―Nov―24 |
The ADAMTS13-von Willebrand factor axis in COVID-19 patients |
Ilaria Mancini, Luciano Baronciani, Andrea Artoni, Paola Colpani, Marina Biganzoli, Giovanna Cozzi, Cristina Novembrino, Massimo Boscolo Anzoletti, Valentina De Zan, Maria Teresa Pagliari, Roberta Gualtierotti, Stefano Aliberti, Mauro Panigada, Giacomo Grasselli, Francesco Blasi, Flora Peyvandi |
| 89 |
[GO] |
2020―Nov―24 |
Thromboinflammation in COVID-19: Can α
2
-Macroglobulin Help to Control the Fire? |
Rainer Seitz, Lutz Gürtler, Wolfgang Schramm |
| 90 |
[GO] |
2020―Nov―21 |
Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia |
Leo Nicolai, Alexander Leunig, Sophia Brambs, Rainer Kaiser, Markus Joppich, Marie Hoffknecht, Christoph Gold, Anouk Engel, Vivien Polewka, Maximilian Muenchhoff, Johannes C. Hellmuth, Adrian Ruhle, Stephan Ledderose, Tobias Weinberger, Heiko Schulz, Clemens Scherer, Martina Rudelius, Michael Zoller, Oliver T. Keppler, Bernhard Zwißler, Michael von Bergwelt-Baildon, Stefan Kääb, Ralf Zimmer, Roman D. Bülow, Saskia von Stillfried, Peter Boor, Steffen Massberg, Kami Pekayvaz, Konstantin Stark |
| 91 |
[GO] |
2020―Oct―29 |
Is there a role for the ACE2 receptor in SARS-CoV-2 interactions with platelets? |
Robert A. Campbell, Eric Boilard, Matthew T. Rondina |
| 92 |
[GO] |
2020―Oct―09 |
COMMENT ON AN ARTICLE: „Coagulopathy in COVID-19“ |
Omer Ć. Ibrahimagić, Dževdet Smajlović, Zikrija Dostović, Suljo Kunić, Aida Šehanović, Biljana Kojić |
| 93 |
[GO] |
2020―Sep―18 |
COVID-19 patients exhibit reduced procoagulant platelet responses |
Frederik Denorme, Bhanu Kanth Manne, Irina Portier, Aaron C. Petrey, Elizabeth A. Middleton, Benjamin T. Kile, Matthew T. Rondina, Robert A. Campbell |
| 94 |
[GO] |
2020―Sep―18 |
Defibrotide in the COVID-19 coagulopathy: What is the timing? |
Antonio Macciò, Clelia Madeddu, Giovanni Caocci, Sara Oppi, Giorgio La Nasa |
| 95 |
[GO] |
2020―Sep―05 |
Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration |
Tobias Tritschler, Marie-Eve Mathieu, Leslie Skeith, Marc Rodger, Saskia Middeldorp, Timothy Brighton, Per Morten Sandset, Susan R. Kahn, Derek C. Angus, Marc Blondon, Marc J. Bonten, Marco Cattaneo, Mary Cushman, Lennie P.G. Derde, Maria T. DeSancho, Jean-Luc Diehl, Ewan Goligher, Bernd Jilma, Peter Jüni, Patrick R. Lawler, Marco Marietta, John C. Marshall, Colin McArthur, Carlos Henrique Miranda, Tristan Mirault, Nuccia Morici, Usha Perepu, Christian Schörgenhofer, Michelle Sholzberg, Alex C. Spyropoulos, Steve A. Webb, Ryan Zarychanski, Stéphane Zuily, Grégoire Le Gal |
| 96 |
[GO] |
2020―Sep―02 |
Letter in response to: Coagulation markers are independent predictors of increased oxygen requirements and thrombosis in COVID-19 |
Pervinder bhogal, Melanie Jensen, George Collins, Oliver Spooner, Levansri Makalanda, Daniel Hart, Ounali Jaffer |
| 97 |
[GO] |
2020―Sep―02 |
COVID-19 Coagulopathy in Pregnancy: Critical Review, Preliminary Recommendations and ISTH Registry - Communication from the ISTH SSC for Women’s Health |
Rezan Abdul Kadir, Takao Kobayashi, Toshiaki Iba, Offer Erez, Jecko Thachil, Sajida Kazi, Ann Kinga Malinowski, Maha Othman |
| 98 |
[GO] |
2020―Aug―31 |
2020 - Year of COVID-19 |
David Lillicrap, James H. Morrissey |
| 99 |
[GO] |
2020―Aug―29 |
Response to “Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance and their limitation”: don’t throw the baby out with the bathwater |
C. Nougier, R. Benoit, Y. Dargaud |
| 100 |
[GO] |
2020―Aug―29 |
Incidence of Deep Vein Thrombosis among non-ICU Patients Hospitalized for COVID-19 Despite Pharmacological Thromboprophylaxis: |
Angelo Porfidia, Angelo Santoliquido, Giulia Cammá, Enrica Porceddu, Roberto Pola |
| 101 |
[GO] |
2020―Aug―29 |
Response to Maccio et al., “Multifactorial Pathogenesis of COVID-19-related Coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?” |
Edward Richardson, Carmelo Carlo-Stella, Ruben Jara, Israel Vlodavsky, Massimo Iacobelli, Jawed Fareed, Clifton Mo, Peter O'Gorman, Gregory Yanik, Marta Palomo, Maribel Diaz-Ricart, Jose M. Moraleda |
| 102 |
[GO] |
2020―Aug―29 |
Consensus-Based Clinical Recommendations and Research Priorities for Anticoagulant Thromboprophylaxis in Children Hospitalized for COVID-19-Related Illness |
Neil A. Goldenberg, Anthony Sochet, Manuela Albisetti, Tina Biss, Mariana Bonduel, Julie Jaffray, Graeme MacLaren, Paul Monagle, Sarah O’Brien, Leslie Raffini, Shoshana Revel-Vilk, Nongnuch Sirachainan, Suzan Williams, Ayesha Zia, Christoph Male |
| 103 |
[GO] |
2020―Aug―28 |
Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19 |
Antoine Rauch, Julien Labreuche, Fanny Lassalle, Julien Goutay, Morgan Caplan, Leslie Charbonnier, Aurelien Rohn, Emmanuelle Jeanpierre, Annabelle Dupont, Alain Duhamel, Karine Faure, Marc Lambert, Eric Kipnis, Delphine Garrigue, Peter J. Lenting, Julien Poissy, Sophie Susen |
| 104 |
[GO] |
2020―Aug―13 |
Studies on hemostasis in COVID-19 deserve careful reporting of the laboratory methods, their significance and their limitations |
Michael Hardy, Jonathan Douxfils, Marion Bareille, Sarah Lessire, Isabelle Gouin-Thibault, Pierre Fontana, Thomas Lecompte, François Mullier |
| 105 |
[GO] |
2020―Aug―07 |
Circulating endothelial progenitors are increased in Covid-19 patients and correlate with SARS-CoV-2 RNA in severe cases |
Patrizia Mancuso, Antonio Gidaro, Giuliana Gregato, Alessandro Raveane, Paola Cremonesi, Jessica Quarna, Sonia Caccia, Luca Gusso, Stefano Rusconi, Andrea Giacomelli, Chiara Cogliati, Francesco Bertolini |
| 106 |
[GO] |
2020―Aug―07 |
In vitro
hypercoagulability and ongoing
in vivo
activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation |
Annabel Blasi, Fien A. Meijenfeldt, Jelle Adelmeijer, Andrea Calvo, Cristina Ibañez, Juan Perdomo, Juan Carlos Reverter, Ton Lisman |
| 107 |
[GO] |
2020―Aug―07 |
Is the COVID-19 thrombotic catastrophe complement-connected? |
Edward M. Conway, Edward L.G. Pryzdial |
| 108 |
[GO] |
2020―Jul―29 |
Hypoxia - an overlooked trigger for thrombosis in COVID-19 and other critically ill patients |
Jecko Thachil |
| 109 |
[GO] |
2020―Jul―29 |
Chronic Therapeutic Anticoagulation is Associated with Decreased Thrombotic Complications in SARS-CoV-2 Infection |
Daniel J. Lachant, Neil A. Lachant, Peter Kouides, Stephen Rappaport, Paritosh Prasad, R. James White |
| 110 |
[GO] |
2020―Jul―21 |
Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID-19 |
Rushad Patell, Thomas Bogue, Poorva Bindal, Anita Koshy, Mwanasha Merrill, William C Aird, Kenneth A Bauer, Jeffrey I Zwicker |
| 111 |
[GO] |
2020―Jul―21 |
Multifactorial pathogenesis of COVID-19-related coagulopathy. Can defibrotide have a role in the early phases of coagulation disorders? |
Antonio Macciò, Clelia Madeddu, Giovanni Caocci, Giorgio La Nasa |
| 112 |
[GO] |
2020―Jul―21 |
Fibrinolysis and COVID-19: a tale of two sites? |
Charithani B. Keragala, Robert L. Medcalf, Paul S. Myles |
| 113 |
[GO] |
2020―Jul―21 |
The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: the Padua province experience |
Raffaele Pesavento, Davide Ceccato, Giampaolo Pasquetto, Jacopo Monticelli, Lucia Leone, Annachiara Frigo, Davide Gorgi, Anna Postal, Giuseppe Maria Marchese, Alberto Cipriani, Alois Saller, Cristiano Sarais, Pietro Criveller, Marco Gemelli, Federico Capone, Paola Fioretto, Claudio Pagano, Marco Rossato, Angelo Avogaro, Paolo Simioni, Paolo Prandoni, Roberto Vettor |
| 114 |
[GO] |
2020―Jul―15 |
Hypofibrinolytic state and high thrombin generation may play a major role in sars-cov2 associated thrombosis |
Christophe Nougier, Remi Benoit, Marie Simon, Helene Desmurs-Clavel, Guillaume Marcotte, Laurent Argaud, Jean Stephane David, Aurelie Bonnet, Claude Negrier, Yesim Dargaud |
| 115 |
[GO] |
2020―Jul―14 |
COVID-19-associated coagulopathy - Hypothesis: Are Children protected due to enhanced thrombin inhibition by higher α
2
-Macroglobulin (α2-M)? |
Wolfgang Schramm, Rainer Seitz, Lutz Gürtler |
| 116 |
[GO] |
2020―Jul―13 |
ISTH DIC Subcommittee Communication on Anticoagulation in COVID-19 |
Jecko Thachil, Nicole P. Juffermans, Marco Ranucci, Jean M. Connors, Theodore E. Warkentin, Thomas L. Ortel, Marcel Levi, Toshiaki Iba, Jerrold H. Levy |
| 117 |
[GO] |
2020―Jul―13 |
Are chilblains a skin expression of COVID-19 microangiopathy? |
Marie Baeck, Anne Herman, Caroline Peeters, Liliane Marot, Cedric Hermans |
| 118 |
[GO] |
2020―Jul―07 |
Incidence of Deep Vein Thrombosis among non-ICU Patients Hospitalized for COVID-19 Despite Pharmacological Thromboprophylaxis |
Angelo Santoliquido, Angelo Porfidia, Antonio Nesci, Giuseppe De Matteis, Giuseppe Marrone, Enrica Porceddu, Giulia Cammà, Igor Giarretta, Massimo Fantoni, Francesco Landi, Antonio Gasbarrini, Roberto Pola, Valeria Abbate, Nicola Acampora, Giovanni Addolorato, Fabiana Agostini, Maria E. Ainora, Elena Amato, Gloria Andriollo, Brigida E. Annicchiarico, Mariangela Antonelli, Gabriele Antonucci, Armuzzi Alessandro, Christian Barillaro, Fabiana Barone, Rocco D.A. Bellantone, Andrea Bellieni, Andrea Benicchi, Francesca Benvenuto, Filippo Berloco, Roberto Bernabei, Antonio Bianchi, Luigi M. Biasucci, Stefano Bibbò, Federico Biscetti, Nicola Bonadia, Alberto Borghetti, Giulia Bosco, Silvia Bosello, Vincenzo Bove, Giulia Bramato, Vincenzo Brandi, Dario Bruno, Maria C. Bungaro, Alessandro Buonomo, Livia Burzo, Angelo Calabrese, Andrea Cambieri, Giulia Cammà, Marcello Candelli, Gennaro Capalbo, Lorenzo Capaldi, Esmeralda Capristo, Luigi Carbone, Silvia Cardone, Angelo Carfì, Annamaria Carnicelli, Cristiano Caruso, Francesco A. Casciaro, Lucio Catalano, Roberto Cauda, Andrea L. Cecchini, Lucia Cerrito, Michele Ciaburri, Rossella Cianci, Sara Cicchinelli, Arturo Ciccullo, Francesca Ciciarello, Antonella Cingolani, Maria C. Cipriani, Gaetano Coppola, Andrea Corsello, Federico Costante, Marcello Covino, Stefano D'Addio, Alessia D'Alessandro, Maria E. D'alfonso, Emanuela D'Angelo, Francesca D'Aversa, Fernando Damiano, Tommaso De Cunzo, Giuseppe De Matteis, Martina De Siena, Francesco De Vito, Valeria Del Gatto, Paola Del Giacomo, Fabio Del Zompo, Davide Della Polla, Luca Di Gialleonardo, Simona Di Giambenedetto, Roberta Di Luca, Luca Di Maurizio, Alex Dusina, Alessandra Esperide, Domenico Faliero, Cinzia Falsiroli, Massimo Fantoni, Annalaura Fedele, Daniela Feliciani, Andrea Flex, Evelina Forte, Francesco Franceschi, Laura Franza, Barbara Funaro, Mariella Fuorlo, Domenico Fusco, Maurizio Gabrielli, Eleonora Gaetani, Antonella Gallo, Giovanni Gambassi, Matteo Garcovich, Antonio Gasbarrini, Irene Gasparrini, Silvia Gelli, Antonella Giampietro, Laura Gigante, Gabriele Giuliano, Giorgia Giuliano, Bianca Giupponi, Elisa Gremese, Caterina Guidone, Amerigo Iaconelli, Angela Iaquinta, Michele Impagnatiello, Riccardo Inchingolo, Raffaele Iorio, Immacolata M. Izzi, Cristina Kadhim, Daniele I. La Milia, Francesco Landi, Giovanni Landi, Rosario Landi, Massimo Leo, Antonio Liguori, Rosa Liperoti, Marco M. Lizzio, Maria R. Lo Monaco, Pietro Locantore, Francesco Lombardi, Loris Lopetuso, Valentina Loria, Angela R. Losito, Andrea Lupascu, Noemi Macerola, Giuseppe Maiuro, Francesco Mancarella, Francesca Mangiola, Alberto Manno, Debora Marchesini, Giuseppe Marrone, Ilaria Martis, Anna M. Martone, Emanuele Marzetti, Maria V. Matteo, Luca Miele, Alessio Migneco, Irene Mignini, Alessandro Milani, Domenico Milardi, Massimo Montalto, Flavia Monti, Davide Moschese, Barbara P.L. Mothaenje, Celeste A. Murace, Rita Murri, Marco Napoli, Elisabetta Nardella, Gerlando Natalello, Simone M. Navarra, Antonio Nesci, Alberto Nicoletti, Tommaso Nicoletti, Rebecca Nicolò, Nicola Nicolotti, Enrico C. Nista, Eugenia Nuzzo, Veronica Ojetti, Francesco C. Pagano, Cristina Pais, Alfredo Papa, Luigi G. Papparella, Mattia Paratore, Giovanni Pecorini, Simone Perniola, Erika Pero, Giuseppe Perrinello, Luca Petricca, Martina Petrucci, Chiara Picarelli, Andrea Piccioni, Giulia Pignataro, Raffaele Pignataro, Marco Pizzoferrato, Fabrizio Pizzolante, Roberto Pola, Caterina Policola, Maurizio Pompili, Valerio Pontecorvi, Francesca Ponziani, Valentina Popolla, Enrica Porceddu, Angelo Porfidia, Giuseppe Privitera, Gabriele Pulcini, Simona Racco, Francesca Raffaelli, Gian L. Rapaccini, Luca Richeldi, Emanuele Rinninella, Sara Rocchi, Stefano Romano, Federico Rosa, Laura Rossi, Raimondo Rossi, Enrica Rossini, Elisabetta Rota, Fabiana Rovedi, Gabriele Rumi, Andrea Russo, Luca Sabia, Andrea Salerno, Sara Salini, Lucia Salvatore, Dehara Samori, Maurizio Sanguinetti, Luca Santarelli, Paolo Santini, Angelo Santoliquido, Francesco Santopaolo, Michele C. Santoro, Francesco Sardeo, Caterina Sarnari, Luisa Saviano, Tommaso Schepis, Francesca Schiavello, Giancarlo Scoppettuolo, Luisa Sestito, Carlo Settanni, Valentina Siciliano, Benedetta Simeoni, Andrea Smargiassi, Domenico Staiti, Leonardo Stella, Eleonora Taddei, Rossella Talerico, Enrica Tamburrini, Claudia Tarli, Pietro Tilli, Enrico Torelli, Matteo Tosato, Alberto Tosoni, Luca Tricoli, Marcello Tritto, Mario Tumbarello, Anita M. Tummolo, Federico Valletta, Giulio Ventura, Lucrezia Verardi, Lorenzo Vetrone, Giuseppe Vetrugno, Elena Visconti, Raffaella Zaccaria, Lorenzo Zelano, Lorenzo Zileri Dal Verme, Giuseppe Zuccalà |
| 119 |
[GO] |
2020―Jul―03 |
Specific coagulation markers may provide more therapeutic targets in COVID-19 patients receiving prophylactic anticoagulant |
Ning Tang, Huan Bai, Dongsheng Xiong, Ziyong Sun |
| 120 |
[GO] |
2020―Jul―03 |
Antiphospholipid antibodies in patients with COVID-19: a relevant observation? |
Katrien M.J. Devreese, Eleni A. Linskens, Dominique Benoit, Harlinde Peperstraete |
| 121 |
[GO] |
2020―Jul―03 |
Living through a pandemic - A time for clarity, courage and truth |
Claire McLintock |
| 122 |
[GO] |
2020―Jul―01 |
Response to ‘the association between D-dimer in COVID-19 patients and mortality remains beset of uncertainties’ |
Litao Zhang, Xinsheng Yan, Yiyao Gong, Zhenlu Zhang |
| 123 |
[GO] |
2020―Jul―01 |
COVID-19: a collision of complement, coagulation and inflammatory pathways |
Anoop J. Chauhan, Laura J. Wiffen, Thomas P. Brown |
| 124 |
[GO] |
2020―Jul―01 |
Lupus anticoagulant is frequent in patients with Covid-19: Response to Reply |
Inès Harzallah, Agathe Debliquis, Bernard Drénou |
| 125 |
[GO] |
2020―Jun―19 |
Coagulopathy in COVID-19 |
Toshiaki Iba, Jerrold H. Levy, Marcel Levi, Jecko Thachil |
| 126 |
[GO] |
2020―Jun―19 |
Curative anticoagulation prevents endothelial lesion in COVID-19 patients |
Lina Khider, Nicolas Gendron, Guillaume Goudot, Richard Chocron, Caroline Hauw-Berlemont, Charles Cheng, Nadia Rivet, Helene Pere, Ariel Roffe, Sébastien Clerc, David Lebeaux, Benjamin Debuc, David Veyer, Bastien Rance, Pascale Gaussem, Sébastien Bertil, Cécile Badoual, Philippe Juvin, Benjamin Planquette, Emmanuel Messas, Olivier Sanchez, Jean-Sébastien Hulot, Jean-Luc Diehl, Tristan Mirault, David M. Smadja |
| 127 |
[GO] |
2020―Jun―16 |
Fibrinolysis and COVID-19: a plasmin paradox |
Robert L. Medcalf, Charithani B. Keragala, Paul S. Myles |
| 128 |
[GO] |
2020―Jun―11 |
Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis |
María Isabel Rivas-Pollmar, María Teresa Álvarez-Román, Nora V. Butta-Coll, Mónica Martín Salces, Sara García-Barcenilla, Victor Jiménez-Yuste |
| 129 |
[GO] |
2020―Jun―11 |
Response to ‘all these D-dimers in COVID-19’ |
Litao Zhang |
| 130 |
[GO] |
2020―Jun―11 |
The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on Fibrinolysis |
Jecko Thachil, Colin Longstaff, Emmanuel J. Favaloro, Giuseppe Lippi, Tetsumei Urano, Paul Y. Kim |
| 131 |
[GO] |
2020―Jun―04 |
The association between D-dimers in COVID-19 patients and mortality remains beset of uncertainties |
Jean-Christophe Gris, Paul Loubet, Claire Roger, Eva Cochery-Nouvellon, Jean-Marc Mauboussin, Laurent Muller, Sylvie Bouvier, Didier Laureillard, Saber Davide Barbar, Érick Mercier, Jean-Yves Lefrant, Albert Sotto |
| 132 |
[GO] |
2020―Jun―03 |
Forum article: The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states |
Jecko Thachil |
| 133 |
[GO] |
2020―May―29 |
All those D-dimers in COVID-19 |
Jecko Thachil |
| 134 |
[GO] |
2020―May―29 |
Frequency of lupus anticoagulant in Covid-19 patients |
Inès Harzallah, Agathe Debliquis, Bernard Drénou |
| 135 |
[GO] |
2020―May―29 |
Reply to ‘Ibuprofen and thromboembolism in SARS-COV2’ |
Songping Cui, Shuo Chen, Lihui Ke |
| 136 |
[GO] |
2020―May―28 |
Macrothrombosis and stroke in patients with mild Covid-19 infection |
Michael G. Fara, Laura K. Stein, Maryna Skliut, Susan Morgello, Johanna T. Fifi, Mandip S. Dhamoon |
| 137 |
[GO] |
2020―May―27 |
Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19 |
Alex C. Spyropoulos, Jerrold H. Levy, Walter Ageno, Jean Marie Connors, Beverley J Hunt, Toshiaki Iba, Marcel Levi, Charles Marc Samama, Jecko Thachil, Dimitrios Giannis, James D. Douketis |
| 138 |
[GO] |
2020―May―19 |
Heparin - an old drug with multiple potential targets in Covid-19 therapy |
Ulf Lindahl, Jin-Ping Li |
| 139 |
[GO] |
2020―May―16 |
Ibuprofen and thromboembolism in SARS-COV2 |
Arian Arjomandi Rad, Robert Vardanyan, Natalie R Tas |
| 140 |
[GO] |
2020―May―14 |
Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients |
Francisco Sandro Menezes-Rodrigues, José Gustavo Padrão Tavares, Marcelo Pires de Oliveira, Rafael Guzella de Carvalho, Paolo Ruggero Errante, Murched Omar Taha, Djalma José Fagundes, Afonso Caricati-Neto |
| 141 |
[GO] |
2020―May―14 |
Response to “uncertainties on the prognostic value of D-dimers in COVID-19 patients” |
Litao Zhang |
| 142 |
[GO] |
2020―May―07 |
Coagulopathy of COVID-19 and antiphospholipid antibodies |
Nathan T. Connell, Elisabeth M. Battinelli, Jean M. Connors |
| 143 |
[GO] |
2020―May―07 |
Response to 'What do monitoring platelet counts in COVID-19 teach us?' |
Xiaobo Yang, You Shang |
| 144 |
[GO] |
2020―May―07 |
Response to “Lupus anticoagulant is frequent in patients with Covid-19” |
Ning Tang |
| 145 |
[GO] |
2020―May―05 |
Incidence of venous thromboembolism in hospitalized patients with COVID-19 |
Saskia Middeldorp, Michiel Coppens, Thijs F. van Haaps, Merijn Foppen, Alexander P. Vlaar, Marcella C.A. Müller, Catherine C.S. Bouman, Ludo F.M. Beenen, Ruud S. Kootte, Jarom Heijmans, Loek P. Smits, Peter I. Bonta, Nick van Es |
| 146 |
[GO] |
2020―Apr―29 |
Hereditary Haemorrhagic Telangiectasia: a disease not to be forgotten during the COVID-19 pandemic |
Eleonora Gaetani, Giulio Cesare Passali, Maria Elena Riccioni, Annalisa Tortora, Roberto Pola, Guido Costamagna, Antonio Gasbarrini |
| 147 |
[GO] |
2020―Apr―28 |
Uncertainties on the prognostic value of D-dimers in COVID-19 patients |
Jean-Christophe Gris, Isabelle Quéré, Antonia Pérez-Martin, Jean-Yves Lefrant, Albert Sotto |
| 148 |
[GO] |
2020―Apr―28 |
What do monitoring platelet counts in COVID-19 teach us? |
Jecko Thachil |
| 149 |
[GO] |
2020―Apr―28 |
DIC in COVID-19: Implications for Prognosis and Treatment? |
Rainer Seitz, Wolfgang Schramm |
| 150 |
[GO] |
2020―Apr―24 |
Type and dose of heparin in COVID-19 |
Jecko Thachil, Ning Tang, Satoshi Gando, Anna Falanga, Marcel Levi, Cary Clark, Toshiaki Iba, Marco Cattaneo |
| 151 |
[GO] |
2020―Apr―24 |
Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19 |
Claire S Whyte, Gael B Morrow, Joanne L Mitchell, Pratima Chowdary, Nicola J Mutch |
| 152 |
[GO] |
2020―Apr―24 |
Direct oral anticoagulant plasma levels striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents. The Cremona experience |
Sophie Testa, Paolo Prandoni, Oriana Paoletti, Rossella Morandini, Maurizio Tala, Claudia Dellanoce, Matteo Giorgi-Pierfranceschi, Monia Betti, Gian Battista Danzi, Angelo Pan, Gualtiero Palareti |
| 153 |
[GO] |
2020―Apr―23 |
Laboratory haemostasis monitoring in COVID-19 |
Jecko Thachil, Ning Tang, Satoshi Gando, Anna Falanga, Marcel Levi, Cary Clark, Toshiaki Iba |
| 154 |
[GO] |
2020―Apr―23 |
Lupus anticoagulant is frequent in patients with Covid-19 |
Inès Harzallah, Agathe Debliquis, Bernard Drénou |
| 155 |
[GO] |
2020―Apr―22 |
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients |
Jean-François Llitjos, Maxime Leclerc, Camille Chochois, Jean-Michel Monsallier, Michel Ramakers, Malika Auvray, Karim Merouani |
| 156 |
[GO] |
2020―Apr―19 |
D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19 |
Litao Zhang, Xinsheng Yan, Qingkun Fan, Haiyan Liu, Xintian Liu, Zejin Liu, Zhenlu Zhang |
| 157 |
[GO] |
2020―Apr―17 |
Thromboinflammation and the hypercoagulability of COVID-19 |
Jean M. Connors, Jerrold H. Levy |
| 158 |
[GO] |
2020―Apr―17 |
RE: ISTH interim guidance to recognition and management of coagulopathy in COVID-19 |
Satoshi Akima, Claire McLintock, Beverley J Hunt |
| 159 |
[GO] |
2020―Apr―17 |
Potential of Heparin and Nafamostat Combination Therapy for COVID-19 |
Hidesaku Asakura, Haruhiko Ogawa |
| 160 |
[GO] |
2020―Apr―17 |
Thrombocytopenia and Its Association with Mortality in Patients with COVID-19 |
Xiaobo Yang, Qingyu Yang, Yaxin Wang, Yongran Wu, Jiqian Xu, Yuan Yu, You Shang |
| 161 |
[GO] |
2020―Apr―17 |
The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome |
Marco Ranucci, Andrea Ballotta, Umberto Di Dedda, Ekaterina Bayshnikova, Marco Dei Poli, Marco Resta, Mara Falco, Gianni Albano, Lorenzo Menicanti |
| 162 |
[GO] |
2020―Apr―17 |
Hypercoagulability of COVID-19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis |
Mauro Panigada, Nicola Bottino, Paola Tagliabue, Giacomo Grasselli, Cristina Novembrino, Veena Chantarangkul, Antonio Pesenti, Fora Peyvandi, Armando Tripodi |
| 163 |
[GO] |
2020―Apr―17 |
ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A Comment |
Christopher D. Barrett, Hunter B. Moore, Michael B. Yaffe, Ernest E. Moore |
| 164 |
[GO] |
2020―Apr―17 |
Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy' |
Ning Tang |
| 165 |
[GO] |
2020―Apr―17 |
Reply to "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy" |
Rubén Coto-Hernández, María Teresa Fábregas Ruano |
| 166 |
[GO] |
2020―Apr―16 |
COVID-19: 2020 a year in turmoil |
David Lillicrap, James H. Morrissey |
| 167 |
[GO] |
2020―Apr―15 |
Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19 |
Marisa Dolhnikoff, Amaro Nunes Duarte-Neto, Renata Aparecida de Almeida Monteiro, Luiz Fernando Ferraz da Silva, Ellen Pierre de Oliveira, Paulo Hilário Nascimento Saldiva, Thais Mauad, Elnara Marcia Negri |
| 168 |
[GO] |
2020―Apr―15 |
Impact of the COVID-19 pandemic on therapeutic choices in Thrombosis-Hemostasis |
C. Hermans, C. Lambert |
| 169 |
[GO] |
2020―Apr―15 |
Venous thromboembolism in COVID-19 patients |
Angelo Porfidia, Roberto Pola |
| 170 |
[GO] |
2020―Apr―15 |
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia |
Deepa RJ Arachchillage, Mike Laffan |
| 171 |
[GO] |
2020―Apr―15 |
Pulmonary thrombosis in 2019-nCoV pneumonia? |
Francesco Marongiu, Elvira Grandone, Doris Barcellona |
| 172 |
[GO] |
2020―Apr―13 |
DOACs and ‘newer’ haemophilia therapies in COVID-19 |
Jecko Thachil, Ning Tang, Satoshi Gando, Anna Falanga, Marco Cattaneo, Marcel Levi, Cary Clark, Toshiaki Iba |
| 173 |
[GO] |
2020―Apr―11 |
Exploring possible mechanisms for COVID-19 induced thrombocytopenia: Unanswered Questions |
Ariunzaya Amgalan, Maha Othman |
| 174 |
[GO] |
2020―Apr―09 |
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia |
Songping Cui, Shuo Chen, Xiunan Li, Shi Liu, Feng Wang |
| 175 |
[GO] |
2020―Apr―08 |
Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series |
Janice Wang, Negin Hajizadeh, Ernest E. Moore, Robert C. McIntyre, Peter K Moore, Livia A. Veress, Michael B. Yaffe, Hunter B. Moore, Christopher D. Barrett |
| 176 |
[GO] |
2020―Apr―02 |
The versatile heparin in COVID-19 |
Jecko Thachil |
| 177 |
[GO] |
2020―Mar―27 |
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy |
Ning Tang, Huan Bai, Xing Chen, Jiale Gong, Dengju Li, Ziyong Sun |
| 178 |
[GO] |
2020―Mar―26 |
ISTH interim guidance on recognition and management of coagulopathy in COVID-19 |
Jecko Thachil, Ning Tang, Satoshi Gando, Anna Falanga, Marco Cattaneo, Marcel Levi, Cary Clark, Toshiaki Iba |
| 179 |
[GO] |
2020―Mar―25 |
Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia |
David Lillicrap |
| 180 |
[GO] |
2020―Feb―19 |
Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia |
Ning Tang, Dengju Li, Xiong Wang, Ziyong Sun |
|
